ResearcherHubei Cancer HospitalNo recent work listed
Huiting Xu
Matched on ORCID iD 0009-0003-8314-9475; OpenAlex author ID A5009977733, A5110388148. Sources: OpenAlex.
Their work
- Papers
- 2 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 4
2021: 1 paper · 2022: none · 2023: 1 paper
Papers 2
- DNA methylation and miR-92a-3p-mediated repression of HIP1R promotes pancreatic cancer progression by activating the PI3K/AKT pathway. First author DOI 10.1111/jcmm.17612↗
- Overexpression of Circular RNA circ_0013587 Reverses Erlotinib Resistance in Pancreatic Cancer Cells Through Regulating the miR-1227/E-Cadherin Pathway. Co-author DOI 10.3389/fonc.2021.754146↗
Closest collaborators
The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Qian Shen · 2 shared papers, 2021–2023 · strength 0.34
- Paper DNA methylation and miR-92a-3p-mediated repression of HIP1R promotes pancreatic cancer progression by activating the PI… DOI 10.1111/jcmm.17612↗
- Paper Overexpression of Circular RNA circ_0013587 Reverses Erlotinib Resistance in Pancreatic Cancer Cells Through Regulating… DOI 10.3389/fonc.2021.754146↗
- Sixian Zhu · 1 shared paper, 2023 · strength 0.19
- Qiang Fu · 1 shared paper, 2023 · strength 0.19
- Qiang Fu · 1 shared paper, 2021 · strength 0.15
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.